Inventor · disambiguated record
David A. Yeowell
Also filed as: SWARINGEN ROY A JR · YEOWELL DAVID A
16 granted patents·8 pending applications·239 citations·filing 1977–2022
94Inventor score
Top patents by PatentIndex Score
24 records- 0197US8883823B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2013·Granted Nov 11, 2014·20 cites·52 claims
- 0293US9371288B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2014·Granted Jun 21, 2016·7 cites·5 claims
- 0393US7405274B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2004·Granted Jul 29, 2008·47 cites·28 claims
- 0492US9115085B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2013·Granted Aug 25, 2015·12 cites·11 claims
- 0592US7871617B2Antibodies that bind to a portion of the VWC domain of connective tissue growth factorFIBROGEN INC·Filed 2008·Granted Jan 18, 2011·16 cites·45 claims
- 0689US9918977B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2016·Granted Mar 20, 2018·3 cites·13 claims
- 0788US10272078B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2018·Granted Apr 30, 2019·2 cites·6 claims
- 0888US9617218B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2015·Granted Apr 11, 2017·5 cites·6 claims
- 0988US4491665AMethod of preparing isomers of bis isoquinolinium compoundsBURROUGHS WELLCOME CO·Filed 1981·Granted Jan 1, 1985·23 cites·1 claims
- 1086US4761418ANovel compoundsBURROUGHS WELLCOME CO·Filed 1985·Granted Aug 2, 1988·47 cites·15 claims
- 1186US4701460ALong duration neuromuscular blocking agentsBURROUGHS WELLCOME CO·Filed 1985·Granted Oct 20, 1987·24 cites·12 claims
- 1286US4144263ABenzyl cyanoacetalsBURROUGHS WELLCOME CO·Filed 1977·Granted Mar 13, 1979·12 cites·14 claims
- 1384US2024076364A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2022·Application pending·0 cites
- 1482US10118897B2Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2017·Granted Nov 6, 2018·2 cites·18 claims
- 1581US4216319ASynthesis of 2,4-diamino-5-benzylpyrimidines using benzyl cyanoacetal intermediatesBURROUGHS WELLCOME CO·Filed 1978·Granted Aug 5, 1980·11 cites·19 claims
- 1675US9034643B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2012·Granted May 19, 2015·1 cites·12 claims
- 1774US2021230259A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2020·Application pending·0 cites
- 1867US2019023778A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2018·Application pending·0 cites
- 1966US4500711ASynthesis of leucovorinBURROUGHS WELLCOME CO·Filed 1980·Granted Feb 19, 1985·7 cites·8 claims
- 2066US2020115344A1Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2019·Application pending·0 cites
- 2164US2019276408A1Crystalline forms of a prolyl hydroxylase inhibitorFIBROGEN INC·Filed 2018·Application pending·0 cites
- 2260US2016257740A1Connective Tissue Growth Factor AntibodiesFIBROGEN INC·Filed 2016·Application pending·0 cites
- 2357US2011091468A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2010·Application pending·0 cites
- 2457US2016024198A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Yeowell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →